Applied DNA Sciences Appoints Joshua Kruger as Chairman

Applied DNA Sciences ( (BNBX) ) just unveiled an announcement.

On November 6, 2025, Applied DNA Sciences appointed Joshua Kruger as Chairman and director, following the resignation of Sanford R. Simon and Judith Murrah’s voluntary resignation as Chairperson. Mr. Kruger, affiliated with Cypress Management LLC and Cypress LLC, is not considered independent under Nasdaq rules. The company has engaged Cypress Management LLC for strategic advisory services and Cypress LLC for digital asset management, with Mr. Kruger having significant economic interests in both entities. These agreements involve substantial financial transactions, including monthly fees and stock warrants, reflecting the company’s strategic focus on growth and asset management in the crypto sector.

Spark’s Take on BNBX Stock

According to Spark, TipRanks’ AI Analyst, BNBX is a Neutral.

Applied DNA Sciences faces substantial financial and operational challenges, as indicated by declining revenues and net losses. Despite some positive strategic moves, such as focusing on LineaRx, the stock suffers from poor technical indicators and valuation metrics. The company’s ongoing financial struggles and the uncertainties highlighted in the earnings call contribute to a low overall stock score.

To see Spark’s full report on BNBX stock, click here.

More about Applied DNA Sciences

Applied DNA Sciences operates in the crypto technology sector, focusing on providing strategic advice, guidance, and technical advisory services. The company is involved in digital asset management and has a market focus on cryptocurrency and digital asset strategies.

Average Trading Volume: 1,335,469

Technical Sentiment Signal: Strong Sell

Current Market Cap: $15.42M

For a thorough assessment of BNBX stock, go to TipRanks’ Stock Analysis page.